Bacillus calmette-guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: A randomised prospective study

Massimo Porena, Michele Del Zingaro, Massimo Lazzeri, Luigi Mearini, Antonella Giannantoni, Vittorio Bini, Elisabetta Costantini

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bacillus calmette-guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: A randomised prospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences